The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | The diagnostic work-up of CBCL
Jean-Philippe Merlio, MD, PhD, Tumor Biology and Tumor Bank, CHU Bordeaux, Pessac, France, discusses the diagnosis of cutaneous B-cell lymphoma (CBCL), commenting on the particular significance of early diagnosis for large cell lymphomas. Prof. Merlio also talks on the importance of accurate diagnosis in the treatment of large B-cell lymphomas, highlighting the use of systemic therapy, rituximab and radiation therapy. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
